Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

PHARMACIE DE L'EUROPE : revenue, balance sheet and financial ratios

PHARMACIE DE L'EUROPE is a French company founded 2 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in SURGERES (17700), this company of category PME shows in 2024 a net income negative of -297 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-25

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - PHARMACIE DE L'EUROPE (SIREN 978330231)
Indicator 2024
Revenue N/C
Net income -297 231 €
EBITDA N/C
Net margin N/C

Revenue and income statement

In 2024, PHARMACIE DE L'EUROPE records a net loss of 297 k€. This deficit will reduce equity on the balance sheet.

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

-297 231 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at -2335%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches -4%. Low autonomy: the company heavily depends on external financing (banks, suppliers).

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

-2335.025%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

-3.939%

Solvency indicators evolution
PHARMACIE DE L'EUROPE

Sector positioning

Debt ratio
-2335.03 2024
2024
Q1: 16.46
Med: 58.48
Q3: 154.77
Excellent

In 2024, the debt ratio of PHARMACIE DE L'EUROPE (-2335.03) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.

Financial autonomy
-3.94% 2024
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Watch

In 2024, the financial autonomy of PHARMACIE DE L'EUROPE (-3.9%) ranks in the bottom 25% of the sector. This ratio represents the share of equity in total financing. Low autonomy may limit investment capacity and increase vulnerability.

Positioning of PHARMACIE DE L'EUROPE in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare PHARMACIE DE L'EUROPE with other companies in the same sector:

Frequently asked questions about PHARMACIE DE L'EUROPE

What is the revenue of PHARMACIE DE L'EUROPE ?

The revenue of PHARMACIE DE L'EUROPE is not publicly disclosed (confidential accounts filed with INPI).

Is PHARMACIE DE L'EUROPE profitable?

PHARMACIE DE L'EUROPE recorded a net loss in 2024.

Where is the headquarters of PHARMACIE DE L'EUROPE ?

The headquarters of PHARMACIE DE L'EUROPE is located in SURGERES (17700), in the department Charente-Maritime.

Where to find the tax return of PHARMACIE DE L'EUROPE ?

The tax return of PHARMACIE DE L'EUROPE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does PHARMACIE DE L'EUROPE operate?

PHARMACIE DE L'EUROPE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.